Ratings TransMedics Group, Inc.

Equities

TMDX

US89377M1099

Real-time Estimate Cboe BZX Other stock markets 12:35:01 2024-04-29 pm EDT			5-day change	1st Jan Change
95.66 ^USD	+3.88%		+10.74%	+21.37%

Apr. 18	Transmedics Group Insider Sold Shares Worth $380,480, According to a Recent SEC Filing	MT
Apr. 05	Transmedics Group Insider Sold Shares Worth $802,084, According to a Recent SEC Filing	MT

Strengths

Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the past twelve months, EPS forecast has been revised upwards.
Analysts covering this company mostly recommend stock overweighting or purchase.
Over the past four months, analysts' average price target has been revised upwards significantly.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

The company is in debt and has limited leeway for investment
Based on current prices, the company has particularly high valuation levels.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
For the past year, analysts have significantly revised downwards their profit estimates.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Advanced Medical Equipment & Technology

	1st Jan change	Capi.	ESG Refinitiv
TRANSMEDICS GROUP, INC.	+21.37%	3.02B	C
THERMO FISHER SCIENTIFIC	+9.02%	219B	B
DANAHER CORPORATION	+7.59%	183B	B-
INTUITIVE SURGICAL, INC.	+11.26%	133B	B-
BOSTON SCIENTIFIC CORPORATION	+25.40%	108B	A-
SIEMENS HEALTHINEERS AG	+0.27%	63.06B	A-
EDWARDS LIFESCIENCES CORPORATION	+12.74%	52.02B	B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B	B+
AGILENT TECHNOLOGIES, INC.	+0.30%	40.37B	A
GE HEALTHCARE TECHNOLOGIES INC.	+13.39%	39.35B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes